Hopefully after the first patient is treated with a positive outcome, Gamida will issue a PR highlighting their success. At that time we might finally appreciate a raise in the share price, albeit in a limited fashion. Due to the probability the company will need to raise more working capital, I suspect this overhang will limit upward movement in the PPS. Just my opinion & perspective.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.